<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03769818</url>
  </required_header>
  <id_info>
    <org_study_id>aswu/181/18</org_study_id>
    <nct_id>NCT03769818</nct_id>
  </id_info>
  <brief_title>Role of Dexamethasone for Erector Spinae Plane Block in Patients Undergoing Total Abdominal Hysterectomy</brief_title>
  <official_title>Role of Adjuvant Dexamethasone for Erector Spinae Plane Block for Postoperative Analgesia in Patients Undergoing Total Abdominal Hysterectomy: A Randomized, Double-blind Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aswan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aswan University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim to study the efficacy of bupivacaine 0.25% with dexamethasone and that of bupivacaine
      0.25% alone for erector spinae plane block for postoperative analgesia in patients undergoing
      total abdominal hysterectomy Group 1: bupivacaine 0.25% + dexamethasone 8 mg

        -  Group 2: bupivacaine 0.25%

        -  Group3: control group A prospective Randomized Interventional double-blind study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Optimal dynamic analgesia is recognized as the key to enhanced recovery following open
      abdominal surgery. In the last decade, there has been a significant shift away from thoracic
      epidural analgesia (TEA) that has been long considered as the gold standard. Various
      techniques have tried to replicate the analgesic efficacy of TEA. They include transversus
      abdominis plane analgesia (TAP), rectus sheath analgesia (RS), wound infusion analgesia (WI)
      and trans muscular quadratus lumborum analgesia. However, each of these techniques has
      specific limitations that prevent them from being the analgesic technique of choice for all
      open abdominal surgeries. Chin et al first described the erector spinae plane (ESP) block for
      providing analgesia following ventral hernia repair. The unique feature of the
      ultrasound-guided truncal blocks is that in all of these techniques, in contrast to
      peripheral nerve blocks, no nerve or plexus needs to be identified: Local anesthesia (LA) is
      injected in a particular muscle plane, in which the injectate spreads and reaches the
      intended nerves. This simple mechanism has made delivery of nerve blocks easy and versatile.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">June 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A prospective Randomized Interventional double-blind study.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Participating patients, surgeons, anesthesiologists and medical investigators who will be involved in the data collection will be all blinded to the patient's group assignment until the collection of data for all cases will be complete for group 1 and 2.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analog score for pain during movement</measure>
    <time_frame>24 hours post operative</time_frame>
    <description>movement-evoked pain measurements ranging from 0 to 10, where 0 no pain and 10 maximum pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual analog score for pain during rest</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>ranging from 0 to 10, where 0 no pain and 10 maximum pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of patients need Fentanyl consumption</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>calculation of the number of patients need Fentanyl consumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of days patients stay in hospital</measure>
    <time_frame>4 weeks</time_frame>
    <description>calculation of number of days patients stay in hospital</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>bupivacaine and dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bilateral ESP block with 20 ml of 0.25% bupivacaine + 4 mg/kg dexamethasone diluted with isotonic saline.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bupivacaine and placebo to dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bilateral ESP block with 20 ml of 0.25% bupivacaine bilaterally plus placebo to dexamethasone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Bilateral ESP block with placebo to bupivacaine bilaterally plus placebo to dexamethasone</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupivacaine</intervention_name>
    <description>Bilateral TAP block with 20 ml of 0.25% bupivacaine</description>
    <arm_group_label>bupivacaine and dexamethasone</arm_group_label>
    <arm_group_label>bupivacaine and placebo to dexamethasone</arm_group_label>
    <other_name>Active Comparator</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexamethasone</intervention_name>
    <description>Bilateral TAP block with 4 mg/kg dexamethasone diluted with isotonic saline.</description>
    <arm_group_label>bupivacaine and dexamethasone</arm_group_label>
    <other_name>active comparator</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo to dexamethasone</intervention_name>
    <description>Bilateral TAP block with placebo to dexamethasone.</description>
    <arm_group_label>bupivacaine and placebo to dexamethasone</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo to bupivacaine</intervention_name>
    <description>Bilateral TAP block with placebo to bupivacaine.</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women ranging age between 30-60 years a who undergoing elective total abdominal
             hysterectomy

        Exclusion Criteria:

          -  Participants had known sensitivity to bupivacaine

          -  Participants had difficulty in intubation

          -  Participants were on chronic pain medication or already on long-term opioids

          -  Participants smokers

          -  Participants with disabilities who were unable to communicate pain levels

          -  refuse to consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>patients undergoing total abdominal hysterectomy</gender_description>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>hany f sallam, md</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aswan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>hany f sallam</last_name>
    <phone>01022336052</phone>
    <phone_ext>002</phone_ext>
    <email>hany.farouk@aswu.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aswan University</name>
      <address>
        <city>Aswan</city>
        <zip>81528</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>hany f sallam, md</last_name>
      <phone>01092440504</phone>
      <phone_ext>002</phone_ext>
      <email>nahla.elsayed@aswu.ed.eg</email>
    </contact>
    <contact_backup>
      <last_name>Nahla w Shady, md</last_name>
      <phone>1019240504</phone>
      <phone_ext>002</phone_ext>
      <email>nahla.elsayed@aswu.edu.eg</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>December 6, 2018</study_first_submitted>
  <study_first_submitted_qc>December 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2018</study_first_posted>
  <last_update_submitted>February 14, 2019</last_update_submitted>
  <last_update_submitted_qc>February 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aswan University Hospital</investigator_affiliation>
    <investigator_full_name>hany farouk</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>erector spinae plane block</keyword>
  <keyword>total abdominal hysterectomy</keyword>
  <keyword>dexamethasone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

